Home

Meridian Venture Partners II GP, L.P.

CIK 1580170 · last filed 2019-08-21

Meridian Venture Partners II GP, L.P. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider sold $2.1M of FOLD on Aug 21, 2019. Across all open-market trades the lifetime net is −$106.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $186.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$186.16M

Companies

3

Total Filings

5

Lifetime Open-Market Net

-$106.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANI PHARMACEUTICALS INC (FOLD) Delisted 10%+ Owner 2,224,771 $14.49 $32.24M -$19.20M 2 2019-08-21
ANIP 10%+ Owner 2,350,559 $79.20 $186.16M -$87.00M 2 2015-03-16
ANI PHARMACEUTICALS INC (BPAX) Delisted 10%+ Owner 2,819,745 — — $0 1 2013-07-01

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-08-21 ANI PHARMACEUTICALS INC (FOLD) Delisted Sell (S) −30,316 -$2.07M EDGAR
2019-08-16 ANI PHARMACEUTICALS INC (FOLD) Delisted Sell (S) −248,096 -$17.13M EDGAR
2015-03-16 ANIP Sell (S) −1,200,000 -$75.60M EDGAR
2014-03-18 ANIP Sell (S) −350,892 -$11.40M EDGAR
2013-07-01 ANI PHARMACEUTICALS INC (BPAX) Delisted Grant (A) +50,755,407 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.